These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

412 related items for PubMed ID: 10566725

  • 21. Cyclophosphamide pulse therapy followed by azathioprine or methotrexate induces long-term remission in patients with steroid-refractory Crohn's disease.
    Schmidt C, Wittig BM, Moser C, Zeitz M, Stallmach A.
    Aliment Pharmacol Ther; 2006 Jul 15; 24(2):343-50. PubMed ID: 16842461
    [Abstract] [Full Text] [Related]

  • 22. Azathioprine as a postoperative prophylaxis reduces symptoms in aggressive Crohn's disease.
    Myrelid P, Svärm S, Andersson P, Almer S, Bodemar G, Olaison G.
    Scand J Gastroenterol; 2006 Oct 15; 41(10):1190-5. PubMed ID: 16990204
    [Abstract] [Full Text] [Related]

  • 23. Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease.
    Ochsenkühn T, Göke B, Sackmann M.
    Am J Gastroenterol; 2002 Aug 15; 97(8):2022-5. PubMed ID: 12190171
    [Abstract] [Full Text] [Related]

  • 24. Randomized controlled azathioprine withdrawal after more than two years treatment in Crohn's disease: increased relapse rate the following year.
    Vilien M, Dahlerup JF, Munck LK, Nørregaard P, Grønbaek K, Fallingborg J.
    Aliment Pharmacol Ther; 2004 Jun 01; 19(11):1147-52. PubMed ID: 15153167
    [Abstract] [Full Text] [Related]

  • 25. Nutritional therapy versus 6-mercaptopurine as maintenance therapy in patients with Crohn's disease.
    Hanai H, Iida T, Takeuchi K, Arai H, Arai O, Abe J, Tanaka T, Maruyama Y, Ikeya K, Sugimoto K, Nakamura T, Nakamura K, Watanabe F.
    Dig Liver Dis; 2012 Aug 01; 44(8):649-54. PubMed ID: 22542605
    [Abstract] [Full Text] [Related]

  • 26. Effect of long-term low-dose prednisone on height velocity and disease activity in pediatric and adolescent patients with Crohn disease.
    Navarro FA, Hanauer SB, Kirschner BS.
    J Pediatr Gastroenterol Nutr; 2007 Sep 01; 45(3):312-8. PubMed ID: 17873743
    [Abstract] [Full Text] [Related]

  • 27. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy.
    Colombel JF, Loftus EV, Tremaine WJ, Pemberton JH, Wolff BG, Young-Fadok T, Harmsen WS, Schleck CD, Sandborn WJ.
    Am J Gastroenterol; 2004 May 01; 99(5):878-83. PubMed ID: 15128354
    [Abstract] [Full Text] [Related]

  • 28. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).
    Fellermann K, Ludwig D, Stahl M, David-Walek T, Stange EF.
    Am J Gastroenterol; 1998 Oct 01; 93(10):1860-6. PubMed ID: 9772045
    [Abstract] [Full Text] [Related]

  • 29. The impact of thiopurines on the risk of surgical recurrence in patients with Crohn's disease after first intestinal surgery.
    Papay P, Reinisch W, Ho E, Gratzer C, Lissner D, Herkner H, Riss S, Dejaco C, Miehsler W, Vogelsang H, Novacek G.
    Am J Gastroenterol; 2010 May 01; 105(5):1158-64. PubMed ID: 20010925
    [Abstract] [Full Text] [Related]

  • 30. Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal.
    Cassinotti A, Actis GC, Duca P, Massari A, Colombo E, Gai E, Annese V, D'Albasio G, Manes G, Travis S, Porro GB, Ardizzone S.
    Am J Gastroenterol; 2009 Nov 01; 104(11):2760-7. PubMed ID: 19623172
    [Abstract] [Full Text] [Related]

  • 31. Medical management of patients with difficult-to-treat inflammatory bowel disease.
    van Hogezand RA.
    Neth J Med; 1994 Aug 01; 45(2):55-9. PubMed ID: 7936006
    [Abstract] [Full Text] [Related]

  • 32. Clinical evolution of luminal and perianal Crohn's disease after inducing remission with infliximab: how long should patients be treated?
    Domènech E, Hinojosa J, Nos P, Garcia-Planella E, Cabré E, Bernal I, Gassull MA.
    Aliment Pharmacol Ther; 2005 Dec 01; 22(11-12):1107-13. PubMed ID: 16305724
    [Abstract] [Full Text] [Related]

  • 33. Long-term results with azathioprine therapy in patients with corticosteroid-dependent Crohn's disease: open-label prospective study.
    Chebli JM, Gaburri PD, De Souza AF, Pinto AL, Chebli LA, Felga GE, Forn CG, Pimentel CF.
    J Gastroenterol Hepatol; 2007 Feb 01; 22(2):268-74. PubMed ID: 17295882
    [Abstract] [Full Text] [Related]

  • 34. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
    Borrelli O, Bascietto C, Viola F, Bueno de Mesquita M, Barbato M, Mancini V, Bosco S, Cucchiara S.
    Dig Liver Dis; 2004 May 01; 36(5):342-7. PubMed ID: 15191204
    [Abstract] [Full Text] [Related]

  • 35. Maintenance of remission in Crohn's disease.
    Gonvers JJ, Juillerat P, Mottet C, Felley C, Burnand B, Vader JP, Michetti P, Froehlich F.
    Digestion; 2005 May 01; 71(1):41-8. PubMed ID: 15711049
    [Abstract] [Full Text] [Related]

  • 36. A report on efficacy and safety of azathioprine in a group of inflammatory bowel disease patients in northwest Greece.
    Christodoulou D, Katsanos K, Baltayannis G, Tzabouras N, Tsianos EV.
    Hepatogastroenterology; 2003 May 01; 50(52):1021-4. PubMed ID: 12845970
    [Abstract] [Full Text] [Related]

  • 37. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine.
    Dilger K, Schaeffeler E, Lukas M, Strauch U, Herfarth H, Müller R, Schwab M.
    Ther Drug Monit; 2007 Feb 01; 29(1):1-5. PubMed ID: 17304143
    [Abstract] [Full Text] [Related]

  • 38. Methotrexate treatment in pediatric Crohn disease patients intolerant or resistant to purine analogues.
    Weiss B, Lerner A, Shapiro R, Broide E, Levine A, Fradkin A, Bujanover Y.
    J Pediatr Gastroenterol Nutr; 2009 May 01; 48(5):526-30. PubMed ID: 19412004
    [Abstract] [Full Text] [Related]

  • 39. [Drug treatment of Crohn's disease].
    van Deventer SJ, Tytgat GN.
    Ned Tijdschr Geneeskd; 1998 May 23; 142(21):1191-5. PubMed ID: 9627451
    [Abstract] [Full Text] [Related]

  • 40. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.
    Baumgart DC, Pintoffl JP, Sturm A, Wiedenmann B, Dignass AU.
    Am J Gastroenterol; 2006 May 23; 101(5):1048-56. PubMed ID: 16573777
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.